Common Anti-inflammatory Medication May Help Prevent Parkinson’s Neurodegeneration, Study Suggests

Common Anti-inflammatory Medication May Help Prevent Parkinson’s Neurodegeneration, Study Suggests
A type of immune cell called Th17 may be a key a promoter of neurodegeneration in Parkinson’s disease by producing the pro-inflammatory molecule interleukin-17 (IL-17), according to a study. Researchers also found that the common anti-inflammatory medication Cosentyx (secukinumab), an antibody against IL-17, seems to prevent this mechanism and the death of nerve cells. The study, “Th17 Lymphocytes Induce Neuronal Cell Death ... read more
Source: Parkinson’s News TodayPublished on 2018-07-24By Jose Marques Lopes, PhD